{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:17:37Z","timestamp":1789233457544,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.jaad.2007.12.035","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T14:00:55Z","timestamp":1202306455000},"page":"625-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"title":["Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial"],"prefix":"10.1016","volume":"58","author":[{"given":"Shanu Kohli","family":"Kurd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"VanVoorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Troxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Badmaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Seykora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.12.035_bib1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","article-title":"Prevalence and treatment of psoriasis in the United Kingdom: a population-based study","volume":"141","author":"Gelfand","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.12.035_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaad.2004.04.014","article-title":"Determinants of quality of life in patients with psoriasis: a study from the US population","volume":"51","author":"Gelfand","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.12.035_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.12.035_bib4","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2007.12.035_bib5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.12.035_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1586\/1744666X.3.2.171","article-title":"An update on the epidemiology and systemic treatment of psoriasis","volume":"3","author":"Kurd","year":"2007","journal-title":"Exp Rev Clin Immunol"},{"key":"10.1016\/j.jaad.2007.12.035_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199503023320907","article-title":"Treatment of psoriasis","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jaad.2007.12.035_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2007.12.035_bib9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archderm.143.9.1191","article-title":"Long-term treatment for severe psoriasis: we're halfway there, with a long way to go","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.12.035_bib10","first-page":"216","article-title":"Alternative therapies commonly used within a population of patients with psoriasis","volume":"58","author":"Fleischer","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2007.12.035_bib11","unstructured":"Peoples Pharmacy. Turmeric eases suffering from psoriasis. Available from: URL:http:\/\/www.healthcentral.com\/peoplespharmacy\/408\/60710.html. Accessed September 3, 2007."},{"key":"10.1016\/j.jaad.2007.12.035_bib12","unstructured":"Jelsoft Enterprises Ltd. Turmeric or curcumin for psoriasis? Available from: URL:http:\/\/www.psoriasis.org\/forum\/archive\/index.php\/t-15803.html. Accessed September 3, 2007."},{"key":"10.1016\/j.jaad.2007.12.035_bib13","unstructured":"Peoples Pharmacy. Turmeric eases psoriasis. Available from: URL:http:\/\/www.buffalonews.com\/opinioncolumns\/columns\/otherlife\/story\/191877.html. Accessed September 3, 2007."},{"key":"10.1016\/j.jaad.2007.12.035_bib14","doi-asserted-by":"crossref","first-page":"30235","DOI":"10.1016\/S0021-9258(17)45855-8","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane)","volume":"270","author":"Singh","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2007.12.035_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-2952(97)00535-2","article-title":"Inhibition of nuclear factor kappaB by direct modification in whole cells\u2013mechanism of action of nordihydroguaiaretic acid, curcumin and thiol modifiers","volume":"55","author":"Brennan","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaad.2007.12.035_bib16","first-page":"337","article-title":"Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells","volume":"35","author":"Han","year":"2002","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.jaad.2007.12.035_bib17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/carcin\/bgg107","article-title":"Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation","volume":"24","author":"Chun","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2007.12.035_bib18","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/carcin\/bgg078","article-title":"Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1","volume":"24","author":"Shishodia","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2007.12.035_bib19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0006-2952(95)00171-U","article-title":"Inhibition of tumor necrosis factor by curcumin, a phytochemical","volume":"49","author":"Chan","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaad.2007.12.035_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-2001-16482","article-title":"A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria","volume":"67","author":"Jang","year":"2001","journal-title":"Planta Med"},{"key":"10.1016\/j.jaad.2007.12.035_bib21","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1016\/j.bmc.2004.08.027","article-title":"Anti-allergic principles from Thai zedoary: structural requirements of curcuminoids for inhibition of degranulation and effect on the release of TNF-alpha and IL-4 in RBL-2H3 cells","volume":"12","author":"Matsuda","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jaad.2007.12.035_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1439-0442.2006.00786.x","article-title":"Effects of curcumin on tumor necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis","volume":"53","author":"Gulcubuk","year":"2006","journal-title":"J Vet Med A Physiol Pathol Clin Med"},{"key":"10.1016\/j.jaad.2007.12.035_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6882-6-10","article-title":"Dose escalation of a curcuminoid formulation","volume":"6","author":"Lao","year":"2006","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jaad.2007.12.035_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.12.035_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000051809","article-title":"Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients","volume":"204","author":"Abeni","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2007.12.035_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2003.09.014","article-title":"A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant end point in the assessment of psoriasis","volume":"50","author":"Carlin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.12.035_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/ajhp\/57.12.1121","article-title":"Turmeric","volume":"57","author":"Grant","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaad.2007.12.035_bib28","first-page":"105","article-title":"Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine","volume":"11","author":"Ireson","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2007.12.035_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2006-960004","article-title":"Pharmacology of Curcuma longa","volume":"57","author":"Ammon","year":"1991","journal-title":"Planta Med"},{"key":"10.1016\/j.jaad.2007.12.035_bib30","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2007.12.035_bib31","unstructured":"Plus M. Turmeric (Curcuma longa Linn) and curcumin. Drugs and supplements. Available from: URL:http:\/\/www.nlm.nih.gov\/medlineplus\/druginfo\/natural\/patient-turmeric.html. Accessed September 3, 2007."},{"key":"10.1016\/j.jaad.2007.12.035_bib32","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/carcin\/16.10.2493","article-title":"Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion","volume":"16","author":"Huang","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jaad.2007.12.035_bib33","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1365-2133.2000.03767.x","article-title":"Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters","volume":"143","author":"Heng","year":"2000","journal-title":"Br J Dermatol"}],"updated-by":[{"DOI":"10.1016\/j.jaad.2008.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000}}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T21:55:31Z","timestamp":1668635731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0190962208000042"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.12.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}